MedTrace Logo

Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot

NCT02877095 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-03-15

Study results available
· View outcomes & findings →

Summary

The Pilot study is designed to evaluate the overall safety and feasibility of a strategy based on subcutaneous delivery of furosemide. It will be used to inform the subsequent evaluation phase of the study (separate protocol). The primary objective of the study is to determine if a strategy of a novel subcutaneous delivery of furosemide is safe and feasible in patients with acute heart failure.

Conditions

  • Acute Heart Failure

Interventions

DRUG

Furosemide

subcutaneous furosemide delivered via subcutaneous pump

Sponsors & Collaborators

  • Adrian Hernandez

    lead OTHER

Principal Investigators

  • Adrian Hernandez, MD · Duke University

  • Eugene Braunwald, MD · Harvard University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-19
Primary Completion
2017-11-07
Completion
2017-11-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02877095 on ClinicalTrials.gov